Copernicus Group IRB announces the release of CGIRB Connexus® 2.0
Connexus, CGIRB’s award-winning e-document management system, is utilized by sponsors, CROs, and sites to manage every phase of the IRB review process. Connexus 2.0 aims to give a complete upgrade to the system’s look and feel, offering a cleaner, faster and more intuitive experience, while still giving users the ability to track submissions, access an electronic file cabinet of all IRB documents and receive instant notification when a submission is complete.
“When it was originally released, Connexus created a major shift in the IRB industry,” said Jennifer Sodrel, CGIRB’s Director, Information Management. “With Connexus 2.0, we’ve updated the look of the user interface, as well as reworking elements to make it simpler to use and moreintuitive. We took care to make sure users of the original Connexus will beable to transition to the new version very easily.”
New features in Connexus 2.0 include:
- Cleaner inboxes for workspace managers.
- Instant access to live chat with CGIRB support personnel
- Links to CGIRB news on the Connexus login screen, for the latest information
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Roche’s Susvimo Lands FDA Approval for Diabetic Retinopathy Based on Phase III Pavilion Trial Data
May 22nd 2025One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months achieved superior improvements on the Diabetic Retinopathy Severity Scale.
